Pharmacological therapies for sarcopenia (testosterone, androgen receptor modulators, ghrelin agonists, myostatin inhibitors, ACE inhibitors) have been evaluated, but they are generally less effective than postulated (idem). This evidence concerns the gene AR and sarcopenia.